Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter

被引:148
作者
Camacho, JA
Obie, C
Biery, B
Goodman, BK
Hu, CA
Almashanu, S
Steel, G
Casey, R
Lambert, M
Mitchell, GA
Valle, D [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynaecol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21218 USA
[5] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada
[6] Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada
关键词
D O I
10.1038/9658
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurospora crassa ARG13 and Saccharomyces cerevisiae ARG11 I en code mitochondrial carrier family (MCF) proteins that transport ornithine across the mitochondrial inner membrane,. We used their sequences to identify EST candidates that partially encode orthologous mammalian transporters. We thereby identified such a gene (ORNT1) that maps to 13q14 and whose expression, similar to that of other urea cycle (UC) components, was high in liver and varied with changes in dietary protein. ORNT1 expression, restores ornithine metabolism in fibroblasts from patients with hyperammonaemia-hyperornithinaemia-homocitrullinuria (HHH) syndrome. In a survey of 11 HHH probands, we identified 3 ORNT1 mutant alleles that account for 21 of 22 possible mutant ORNT1 genes in our patients: F188 Delta which is common in French-Canadian HHH patients and encodes an unstable protein; E180K, which encodes a stable, properly targeted protein that is inactive; and a 13q14 microdeletion. Our results show that ORNT1 encodes the mitochondrial ornithine transporter involved in UC function and is defective in HHH syndrome.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 53 条
  • [1] [Anonymous], NAISSANCE POPULATION
  • [2] Autosomal recessive spastic ataxia of Charlevoix-Saguenay
    Bouchard, JP
    Richter, A
    Mathieu, J
    Brunet, D
    Hudson, TJ
    Morgan, K
    Melançon, SB
    [J]. NEUROMUSCULAR DISORDERS, 1998, 8 (07) : 474 - 479
  • [3] EVIDENCE FOR THE EXISTENCE OF AN ORNITHINE-CITRULLINE ANTIPORTER IN RAT-LIVER MITOCHONDRIA
    BRADFORD, NM
    MCGIVAN, JD
    [J]. FEBS LETTERS, 1980, 113 (02) : 294 - 298
  • [4] Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
    Brais, B
    Bouchard, JP
    Xie, YG
    Rochefort, DL
    Chrétien, N
    Tomé, FMS
    Lafrenière, RG
    Rommens, JM
    Uyama, E
    Nohira, O
    Blumen, S
    Korcyn, AD
    Heutink, P
    Mathieu, J
    Duranceau, A
    Codère, F
    Fardeau, M
    Rouleau, GA
    [J]. NATURE GENETICS, 1998, 18 (02) : 164 - 167
  • [5] Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata
    Braverman, N
    Steel, G
    Obie, C
    Moser, A
    Moser, H
    Gould, SJ
    Valle, D
    [J]. NATURE GENETICS, 1997, 15 (04) : 369 - 376
  • [6] BRODY LC, 1992, J BIOL CHEM, V267, P330
  • [7] Brusilow S. W., 1995, METABOLIC MOL BASES, V1, P1187
  • [8] Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience
    Carter, KC
    Byck, S
    Waters, PJ
    Richards, B
    Nowacki, PM
    Laframboise, R
    Lambert, M
    Treacy, E
    Scriver, CR
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (01) : 61 - 70
  • [9] High-resolution YAC-Cosmid-STS map of human chromosome 13
    Cayanis, E
    Russo, JJ
    Kalachikov, S
    Ye, XL
    Park, SH
    Sunjevaric, I
    Bonaldo, MD
    Lawton, L
    Venkatraj, VS
    Schon, E
    Soares, MB
    Rothstein, R
    Warburton, D
    Edelman, IS
    Zhang, PS
    Efstratiadis, A
    Fischer, SG
    [J]. GENOMICS, 1998, 47 (01) : 26 - 43
  • [10] CHEUNG CW, 1989, J BIOL CHEM, V264, P4038